Apolipoprotein J and Alzheimer's amyloid beta solubility - PubMed (original) (raw)

Apolipoprotein J and Alzheimer's amyloid beta solubility

E Matsubara et al. Biochem J. 1996.

Abstract

Apolipoprotein J (apoJ) has been found associated with soluble amyloid beta (sA beta) in plasma and cerebrospinal fluid in normal individuals and co-deposited with fibrillar A beta in Alzheimer's cerebrovascular and parenchymal lesions. Although studies in vitro and in vivo indicate that apoJ is a major carrier protein for sA beta, its role in the fibrillogenesis process is not known. We report herein that apoJ in its native high-density lipoprotein lipidic environment is fully active to interact with A beta peptides. Furthermore, apoJ prevents aggregation and polymerization of synthetic A beta in vitro. The interaction was stable for at least 14 days at 37 degrees C in physiologic buffers, and the peptide retrieved after complex dissociation at low pH retained its inherent aggregation properties. In addition, the binding to apoJ protects synthetic A beta from proteolytic degradation; both A beta 1-42 and A beta 1-40 were more resistant to proteolysis by trypsin and chymotrypsin when complexed to apoJ. The data suggest that the interaction may preclude sA beta aggregation in biological fluids and point to a protecting role of apoJ for complexed A beta species.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Pathol. 1991 Jul;1(4):263-71 - PubMed
    1. J Neurochem. 1993 Nov;61(5):1965-8 - PubMed
    1. Ann Neurol. 1994 Feb;35(2):245-6 - PubMed
    1. J Clin Invest. 1994 Aug;94(2):860-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1994 Aug 30;91(18):8368-72 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources